SCHEMBL7629487

SCHEMBL7629487

CC(Nc1cccc2ccccc12)[C@@H](O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.51
CYP2C9 P11712 3/20 0.51
CYP2C19 P33261 3/20 0.51
ALOX15 P16050 2/20 0.51
TSHR P16473 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ADRA2C P18825 2/20 0.51
CYP2D6 P10635 2/20 0.51
CHRM2 P08172 1/20 0.51
ADRA1A P35348 1/20 0.51
RGS12 O14924 1/20 0.51
GLA P06280 1/20 0.51
PKM P14618 1/20 0.51
ALOX12 P18054 1/20 0.51
NFKB1 P19838 1/20 0.51
HTR2A P28223 1/20 0.51
THPO P40225 1/20 0.51
GNAI1 P63096 1/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7629478 1.00 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL18351225 0.83 CA12 (0.53) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL7567033 0.80 CA12 (0.53) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL11336488 0.79 CA12 (0.56) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL729010 0.79 IDO1 (0.55) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL32575454 0.79 IDO1 (0.55) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL28126564 0.75 ALDH1A1 (0.52) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL14283739 0.75 CYP2D6 (0.56) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL409050 0.73 CA12 (0.54) CYP3A4CYP2C9CYP2C19ALOX15TSHR
SCHEMBL298855 0.73 CA12 (0.54) CYP3A4CYP2C9CYP2C19ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US claimed
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US disclosed